Victory Capital Management Inc Vaxcyte, Inc. Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Victory Capital Management Inc holds 255,040 shares of PCVX stock, worth $22.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

255,040

Previous 307,516 17.06%

Holding current value

$22.6 Million

Previous $23.2 Million 25.4%

% of portfolio

0.03%

Previous 0.02%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$70.52 - $117.12 $3.7 Million - $6.15 Million	-52,476 Reduced 17.06%	255,040 $29.1 Million
Q2 2024 Aug 05, 2024	BUY	$60.06 - $78.77 $1.6 Million - $2.1 Million	26,641 Added 9.49%	307,516 $23.2 Million
Q1 2024 May 03, 2024	SELL	$59.79 - $81.05 $5.89 Million - $7.99 Million	-98,532 Reduced 25.97%	280,875 $19.2 Million
Q4 2023 Feb 05, 2024	SELL	$45.35 - $63.41 $2.34 Million - $3.27 Million	-51,542 Reduced 11.96%	379,407 $23.8 Million
Q3 2023 Nov 06, 2023	SELL	$46.0 - $53.1 $1.44 Million - $1.66 Million	-31,355 Reduced 6.78%	430,949 $22 Million
Q2 2023 Jul 27, 2023	BUY	$34.66 - $54.07 $2.39 Million - $3.73 Million	69,055 Added 17.56%	462,304 $23.1 Million
Q1 2023 May 02, 2023	BUY	$36.27 - $47.2 $11.8 Million - $15.4 Million	325,536 Added 480.76%	393,249 $14.7 Million
Q4 2022 Feb 10, 2023	BUY	$20.58 - $47.95 $1,255 - $2,924	61 Added 0.09%	67,713 $3.25 Million
Q4 2022 Feb 09, 2023	BUY	$20.58 - $47.95 $239,386 - $557,754	11,632 Added 20.76%	67,652 $3.24 Million
Q3 2022 Nov 02, 2022	SELL	$21.69 - $28.53 $381,960 - $502,413	-17,610 Reduced 23.92%	56,020 $1.34 Million
Q2 2022 Aug 01, 2022	SELL	$17.68 - $26.58 $271,918 - $408,800	-15,380 Reduced 17.28%	73,630 $1.6 Million
Q1 2022 May 04, 2022	BUY	$17.46 - $26.36 $1.55 Million - $2.35 Million	89,010 New	89,010 $2.15 Million
Q4 2020 Feb 01, 2021	SELL	$26.57 - $51.74 $135,560 - $263,977	-5,102 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$26.5 - $55.4 $135,203 - $282,650	5,102 New	5,102 $252,000

Others Institutions Holding PCVX

# of Institutions

352

Shares Held

122M

Call Options Held

775K

Put Options Held

433K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $5.25B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Vaxcyte, Inc. Transaction History